You can buy or sell ARDS and other stocks, options, ETFs, and crypto commission-free!
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-105, AR-101, AR-401, AR-201, and AR-501. Read More The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in San Jose, CA.
San Jose, California
52 Week High
52 Week Low
Expected Nov 12, After Hours